
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Bex2 CRISPR/Cas9 KO Plasmid (h) | sc-404711 | 20 µg | $397.00 |
BEX2 (brain expressed X-linked 2) encodes Bex2, a small, intrinsically disordered protein enriched in neural and other tissues that functions as a context-dependent modulator of transcriptional programs and protein–protein interaction networks. Reported activities place Bex2 at the interface of neurotrophin signaling and stress-response pathways, influencing neuronal differentiation, cell-cycle control, and apoptosis through interactions that can impact MAPK/ERK and related survival signaling. Altered BEX2 expression has been described in several disease-relevant contexts, including neurodevelopmental processes and tumor biology, where it has been associated with changes in proliferation, lineage programs, and treatment response phenotypes. These features make BEX2 a useful node for dissecting signaling-to-transcription coupling and cell-fate decisions in human cellular models.
Bex2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the BEX2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the BEX2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the BEX2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Bex2 protein expression.
This CRISPR knockout system enables efficient generation of BEX2-deficient cell models for investigation of Bex2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.